Titration, properly explained
When to step up, when to hold, when to go back down, and why restarting after a gap is the one genuinely dangerous mistake.
Updated 2026-09-18
Titration exists because these drugs slow stomach emptying substantially, and a body given a therapeutic dose on day one responds badly enough that most people would stop within a fortnight.
The principle is simple: start low, go up slowly, and stop where it works. The complication is that "slowly" is a clinical judgement rather than a fixed schedule, and a lot of programmes run it as a calendar instead — which is how people end up at a dose their body was not ready for.
What is happening pharmacologically
The dose ladder is a tolerance-building protocol, not a marketing device. Each step gives the gut time to adapt before the next increase, which is why skipping rungs produces nausea out of proportion to the dose. It is also why tolerance fades on a break: restart where you left off after several weeks away and you are, physiologically, starting high.
Why you cannot just start at the effective dose
Because your gut needs time to adapt. These drugs slow stomach emptying substantially, and going straight to a therapeutic dose produces nausea and vomiting severe enough that most people would stop within a fortnight. The starting dose buys tolerance, not results — which is why judging the medication on month one is the commonest mistake we see.
The two ladders
| Step | Tirzepatide | Semaglutide |
|---|---|---|
| 1 | 2.5 mg — acclimatisation | 0.25 mg — acclimatisation |
| 2 | 5 mg — first therapeutic dose | 0.5 mg |
| 3 | 7.5 mg | 1 mg — therapeutic |
| 4 | 10 mg — trial dose (19.5% avg) | 1.7 mg |
| 5 | 12.5 mg | 2.4 mg — maintenance (14.9% avg) |
| 6 | 15 mg — maximum (20.9% avg) | — |
Each step is roughly four weeks. That is a default, not a rule, and the trial averages are averages rather than targets.
When to hold
Holding at your current dose for an extra month is a normal clinical decision, not a failure. Hold if side effects have not settled, if you are still losing weight steadily at this dose, or if you simply do not feel ready. A programme that pushes you up regardless is running a schedule rather than treating you.
Important. Holding should be free. On a programme that prices by dose, staying put can feel like paying the same for less — which is a financial pressure on a clinical decision. 6 providers in our table hold one price across the entire ladder, which removes that pressure entirely. See our price tables.
When to step back down
Going down a rung is a legitimate move and an under-used one. Reasons to consider it: side effects that have not settled after several weeks at a dose, appetite suppression so complete that you cannot eat enough protein, or having reached your goal and wanting a maintenance dose rather than a maximum one. Discuss it with your prescriber rather than simply taking less than you were prescribed.
What a good programme does
- Reviews each increase against how you are actually doing, rather than applying it on a timer.
- Makes holding easy to request and does not charge you more for it.
- Answers within days when a dose goes badly, not at the next scheduled appointment.
- Asks before escalating rather than shipping the next dose automatically.
- Has a clear position on what happens if you miss weeks.
Questions worth asking before you start
- How are dose increases decided — by a clinician reviewing my progress, or on a schedule?
- What happens to my price when my dose goes up?
- How do I request to stay at a dose for longer, and does that cost me anything?
- Who do I contact if an increase goes badly, and how quickly do they respond?
- What is your protocol if I miss two or three weeks?
Read next
- Reading your label
What each line on the vial and the paperwork means, and the four things to check the moment the box arrives.
- What happens when you stop
Most people regain a substantial share of the weight. Here is what the research actually found, and what that means for how you plan and budget.
- GLP-1s after 50
These drugs work at any age. The risks are not identical at every age, and the muscle and bone question deserves more attention than it usually gets.
- How to spot a bad seller
The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.
- How to read your prescription
What the abbreviations mean, and the mg-versus-mL distinction that is the one genuine hazard in this category.
Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure
